ARMA Bio
armabio.comEmpowering patients with innovative prostate cancer treatments is our mission. ARMA Bio leverages unique technology to tackle the most pressing challenges in cancer therapeutics addressing treatment resistance. ARMA Bio is an early-stage biotech startup dedicated to developing advanced therapeutics for prostate cancer, leveraging insights from groundbreaking research conducted at Weill Cornell Medicine. Our core development focuses on the Androgen Receptor (AR) and its variant AR-V7. ARMA Bio has developed first-in-class small-molecule “glue degrader” targeting AR-V7 and AR, simultaneously addressing the key driver of prostate cancer and its resistance-conferring variant, in a single treatment.
Is this your company?
If you're responsible for hiring at this company, make sure your company and job information are always up to date to attract top talent from the Visible Hands network.
Something looks off?
Open jobs at ARMA Bio
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.
